Clinical Research Facility

Sandusky, Ohio

We've found

3 trials

at this facility

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Sandusky, OH

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Status: Enrolling, Phase III
Updated: 3/23/2017

from

Sandusky, OH

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Sandusky, OH

Use our guide to learn which trials are right for you!